Effect of Antithrombin, Protein C and Protein S on Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
Authors:
- Xingshun QiXQXingshun Qi
- Hui ChenHCHui Chen
- Guohong HanGHGuohong Han
- 1 July 2013
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 346 (1) , 38-44
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein ThrombosisClinical Gastroenterology and Hepatology, 2012
- The Coagulopathy of Chronic Liver DiseaseNew England Journal of Medicine, 2011
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Impact of Antithrombin III Concentrates on Portal Vein Thrombosis After Splenectomy in Patients With Liver Cirrhosis and HypersplenismAnnals of Surgery, 2010
- Protein C and D‐dimer are related to portal vein thrombosis in patients with liver cirrhosisJournal of Gastroenterology and Hepatology, 2009
- Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutationThrombosis and Haemostasis, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic ThrombophiliaEndoscopy, 2002
- Natural anticoagulants and the liverJournal of Gastroenterology and Hepatology, 1997
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986